104
Views
5
CrossRef citations to date
0
Altmetric
Review

Cost analyses of remifentanil, mivacurium and ropivacaine – a systematic review

, , &
Pages 415-425 | Published online: 02 Mar 2005

Bibliography

  • VAN AKEN H: Ethics, economics and outcome. Can: Opin. Anaesthesia (1997) 10:145–146.
  • •Editorial comment of ethics, economics, and outcome.
  • GLASS PSA, GAN TJ, HOWELL S:A review of the pharmacokinetics and pharmakodynamics of remifentanil.Anesth. Analg. (1999) 89(45):57–514.
  • •A review of the pharmacokinetics and pharmakodynarnics of remifentanil.
  • WILHELM W, WROBEL M, KREUER S,LARSEN R: Remifentanil - EineBestandsaufnahme. Anaesthesist (2003) 52(6):473–494.
  • •A review of the pharmacokinetics and pharmakodynarnics of remifentanil.
  • JOSHI GP, WARNER DS, TWERSKY RS, FLEISCHER LA: A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter Phase IV study.Clin. Anesth. (2002) 14(7):494–499.
  • ••A prospective, randomised, controlled trialcomparing remifentanil with fentanyl.
  • CARTWRIGHT DP, KVALSBVIK 0, CASSUTO J et al.: A randomized, blind comparison of remifentanil and alfentanil during anesthesia for outpatient surgery. Anesth. Analg. (1997) 85:1014–1019.
  • •A prospective, randomised, controlled trial comparing remifentanil with alfentanil.
  • CASATI A, ALBERTIN A, FANELLI Get al.: A comparison of remifentanil and sufentanil as adjuvants during sevoflurane anesthesia with epidural analgesia for upper abdominal surgery: effects on postoperative recovery and respiratory function.Anesth. Analg. (2000) 91:1269–1273.
  • •A prospective, randomised, controlled trial comparing remifentanil with sufentanil.
  • SAVARESE JJ, LIEN CA,BELMONT MR, WASTILA WB: Die klinische Pharmakologie neuer Benzylisochinolin-Diester-Verbindungen. Unter besonderer Beracksichtigung von Cisatracurium und Mivacurium. Andsthesist (1997) 46:840–849.
  • •A review dealing with the pharmacology of muscle relaxants.
  • COOK DR, FREEMAN JA, LAI AA et al.:Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renalfailure. Br. 1 Anaesth. (1992)69(2):580–585.
  • •A prospective, controlled trial examining the pharmacokinetic aspects of mivacurium.
  • MCCLURE JH: Ropivacaine. Br.Anaesth. (1996) 76:300–307.
  • ••A review dealing with ropivacaine.
  • WHITESIDE JB, WILDSMITH JAW:Developments in local anaesthetic drugs. Br. Anaesth. (2001) 87:27–35.
  • •A review dealing with local anaesthetic drugs.
  • ROWE WL: Economics and anaesthesia. Anaesthesia (1998) 53:782–788.
  • •Editorial comment of economic analysis.
  • SPERRY JS: Principles of economicanalysis. Anesthesiology (1997)86(5):1197–1205.
  • •Editorial comment of economic analysis.
  • FINUCANE BT, GANAPATHY S, CARLI F et al.: Prolonged epidural infusion of Ropivacaine (2 mg/mL) after colonic surgery: the impact of adding fentanyl. Anesth. Analg. (2001) 92:1276–1285.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of ropivacaine versus ropivacaine plus fentanyl.
  • MYLES PS, HUNT JO, FLETCHER H et al.: Remifentanil, fentanyl, and cardiac surgery: a double blinded, randomized, controlled trial of costs and outcomes. Anesth. Analg. (2002) 95:805–812.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl.
  • OZKOSE Z, COK 0J, TUNCER B, TUFECIOGLU S, YARDIM S: comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA).Clin. Anesth. (2002) 14(3):161–168.
  • •A prospective, randomised, controlled trial dealing with cost-minimisation of remifentanil versus fentanyl.
  • CASATI A, CAPPELLERI G, BERTI M,FANELLI G, DI BENEDETTO P, TORRI G: Randomized comparison of remifentanil-propofol with a sciatic-femoral nerve block for out-patient knee arthroscopy. Ear: Anaesthesia (2002) 19:109–114.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil-propofol versus sciatic-femoral nerve block.
  • ENGOREN M, LUTHER G, FENN-BUDERER N: A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia. Anesth. Analg. (2001) 93:859–864.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl and sufentanil.
  • EPPLE J, KUBITZ J, SCHMIDT H et al: Comparative analysis of costs of total intravenous anaesthesia with Propofol and remifentanil versus balanced anaesthesia with isoflurane and fentanyl.Anaesthesia (2001) 18:20–28.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl.
  • LOOP T, PRIEBE H-J: Prospective, randomized cost analysis of anesthesia with remifentanil combined with propofol, desflurane, or sevoflurane for otorhinolaryngeal surgery.Acta. Anaesthesia Scand. (2002) 46:1251–1260.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus alfentanil and N20.
  • BEERS RA, CALIMLIM JR, UDDOH E, ESPOSITO BE CAMPORESI EM: A comparison of the cost-effectiveness of remifentanil versus fentanyl as an adjuvant to general anesthesia for outpatient gynecologic surgery. Anesth. Analg. (2000) 91:1420–1425.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl.
  • HEIDVALL M, HEIN A, DAVIDSON S, JAKOBSSON J: Cost comparison between three different general anaesthetic techniques for elective arthroscopy of the knee. Acta. Anaesthesia Scand. (2000) 44:157–162.
  • •A prospective, randomised, controlled trial dealing with cost-minimisation of remifentanil versus fentanyl, alfentanil,Or N20.
  • JELLISH WS, LEONETTI JP, AVRAMOV A, FLUDER E, MURDOCH J: Remifentanil-based anestesia versus a propofol technique for otologic surgical procedures. Otolaryngol. Head Neck Sing. (2000)122(2):222–227.
  • •A prospective, randomised, controlled trial dealing with cost-minimisation of remifentanil versus fentanyl.
  • SUTTNER S, BOLDT J, SCHMIDT C,PIPERS, KUMLE B: Cost analysis of target-controlled infusion-based anesthesia compared with standard anesthesia regimens. Anesth. Analg. (1999) 88:77–82.
  • •A prospective, randomised, controlled trial dealing with the cost-minimisation of remifentanil versus fentanyl in combination with N20.
  • PUURA ATE, RORARIUS MFG, MANNINEN P, HOPPUT S, BAER GA: The costs of intense neuromuscular block for anesthesia during endolaryngealprocedures due to waiting time.Anesth. Analg. (1999) 88:1335–1339.
  • ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of mivacuriurn versus atracuriurn, rocuronium, vecuroniurn, and succinylcoline.
  • SPLINTER WM, ISAAC LA: The pharmacoeconomics of neuromuscular blocking drugs: a perioperative cost-minimization strategy in children. Anesth. Analg. (2001) 93:339–344.
  • •A prospective, randomised, controlled trial dealing with the cost-minimisation ofmivacuriurn versus atractniurn, rocuroniurn, vecuronium and cisatacurium.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.